6533b7d6fe1ef96bd12670b6
RESEARCH PRODUCT
Limberg fasciocutaneous transposition flap for the coverage of an exposed hip implant in a patient affected by ewing sarcoma
Rossella LambertiAntonio NapoletanoGiuseppe A. FerraroGorizio PierettiGiovanni Francesco NicolettiFiorina CasaleMartina Di MartinoPasquale Di CostanzoMario FaenzaMario Faenzasubject
medicine.medical_specialtymedicine.medical_treatmentWound BreakdownWound healingArticleHemipelvectomy03 medical and health sciencesHip implant0302 clinical medicineHematomaNegative-pressure wound therapymedicineFasciocutaneous flapInvasive ProcedureHip implantbusiness.industrymedicine.diseaseSurgeryHemipelvectomy030220 oncology & carcinogenesisSeromaExposed implant030211 gastroenterology & hepatologySurgerySarcomabusinessEwing sarcomadescription
Highlights • Hemipelvectomy with immediate reconstruction with prosthetic devices for the surgical treatment of malignant tumors is an invasive procedure. • The treatment of an exposed hip implant in these cluster of patient is extremely challenging and the literature shows how negative pressure wound therapy and myocutaneous, both pedicled and free, flaps are workhorses in these situations. • The literature shows that the gold standard in the coverage of exposed prosthetic devices and in the treatment of infected non healing wounds is represented by muscular or myocutaneous flap. • In this paper we report a successful coverage of exposed prosthetic hip implant with a local fasciocutaneous flap in a patient in which any other kind of reconstruction was not feasible.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-11-01 | International Journal of Surgery Case Reports |